SPRY

ARS Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Lowenthal Richard EDirector, 10 Percent Owner, Officer: PRESIDENT AND CEO
$658k50k shares
SellDec 10, 2024
$13.16
--
Lowenthal Richard EDirector, 10 Percent Owner, Officer: PRESIDENT AND CEO
$658k50k shares
SellDec 10, 2024
$13.17
--
Tanimoto Sarina10 Percent Owner, Officer: CHIEF MEDICAL OFFICER
$658k50k shares
SellDec 10, 2024
$13.16
--
Tanimoto Sarina10 Percent Owner, Officer: CHIEF MEDICAL OFFICER
$658k50k shares
SellDec 10, 2024
$13.17
--
Chakma JustinChief Business Officer
$658k50k shares
SellDec 10, 2024
$13.15
--
Dorsey BrianChief Operating Officer
$186k15k shares
SellDec 11, 2024
$12.43
--

News

seekingalpha.comARS Pharmaceuticals: Still A Buy As Neffy Access Improvesseekingalpha.comMay 20seekingalpha.comARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 15marketbeat.comARS Pharmaceuticals Q1 Earnings Call Highlightsmarketbeat.comMay 15zacks.comARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimateszacks.comMay 15globenewswire.comARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Updateglobenewswire.comMay 15